Wu, Z., et al., Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci U S A, 2003. 100(15):8880-5.
Wu, Z., R. Powell, and W. Lu, Productive folding of human neutrophil alpha-defensins in vitro without the pro-peptide. J Am Chem Soc, 2003. 125(9):2402-3.
Wu, Z., et al., Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation. Proc Natl Acad Sci U S A, 2004. 101(32):11587-92.
Pazgier, M., et al., Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX. Proc Natl Acad Sci U S A, 2009. 106(12):4665-70.
Liu, M., et al., D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms. Proc Natl Acad Sci U S A, 2010. 107(32):14321-6.
Liu, M., et al., A left-handed solution to peptide inhibition of the p53-MDM2 interaction. Angew Chem Int Ed Engl, 2010. 49(21):3649-52.
Chu, H., et al., Human alpha-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science, 2012. 337(6093):477-81.
Xu, D., et al., Human enteric alpha-defensin 5 promotes Shigella infection by enhancing bacterial adhesion and invasion. Immunity, 2018. 48(6):1233-1244 e6.
Feng, C., et al., Tanshinones: first-in-class inhibitors of the biogenesis of the type 3 secretion system needle of Pseudomonas aeruginosa for antibiotic therapy. ACS Cent Sci, 2019. 5(7):1278-1288.
Li, X., et al., Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for p53 activation and tumor suppression. Acta Pharmaceutica Sinica B, 2021. 11(9):2655-2669.
